文献速递主动脉疾病

华盛顿州腹主动脉瘤相关死亡率在1996至2016年间持续下降

Washington State abdominal aortic aneurysm-related mortality shows a steady decline between 1996 and 2016.
PubMed 文献 · J Vasc Surg · 2019-03-06

该研究基于华盛顿州1996至2016年死亡证明记录,分析腹主动脉瘤(AAA)相关死亡率趋势。结果显示AAA相关死亡率从5.8降至2.2例/10万,下降62.1%,破裂AAA死亡率从3.2降至0.95例/10万。死亡率下降幅度因性别和种族而异,且破裂AAA死亡率存在县际差异。

要点

  • 华盛顿州AAA相关年龄标化死亡率21年间下降62.1%。
  • 男性AAA相关死亡率下降55%,女性下降41%。
  • 白人下降53%,非白人仅下降13%,县际rAAA死亡率有差异。

核心结论

  • 1996至2016年华盛顿州年龄标化AAA相关死亡率下降,破裂AAA死亡率下降尤为明显。
  • AAA相关死亡率下降幅度因性别和种族而异,破裂AAA死亡率存在县际差异。

研究设计与样本

  • 基于华盛顿州1996至2016年死亡证明记录的回顾性人群研究。
  • 研究期间共1,014,039例死亡,其中4,438例(0.4%)将AAA列为根本或相关死因。
  • 以2016年华盛顿州人口为标准计算年龄标化死亡率,采用线性回归比较性别和种族趋势,Kruskal-Wallis检验比较县际破裂AAA死亡率。

主要发现

  • AAA相关死亡率从5.8降至2.2例/10万,下降62.1%。
  • 破裂AAA相关死亡率从3.2降至0.95例/10万,每年下降0.12例/10万(95%CI 0.11-0.14;r²=0.95)。
  • 男性年龄标化AAA相关死亡率下降55%(6.5降至3.0例/10万),女性下降41%(2.4降至1.4例/10万)。
  • 男性死亡时年龄较女性年轻(78.1±9.4岁 vs 81.9±8.6岁;P<.001)。
  • 白人年龄标化AAA相关死亡率下降53%(5.3降至2.5例/10万),非白人下降13%(1.5降至1.3例/10万);县际年龄标化破裂AAA死亡率差异有统计学意义(P<.001)。

临床怎么用

  • 区域AAA相关死亡率下降趋势支持继续人群层面监测和公共卫生干预。
  • 性别和种族间下降幅度差异提示需关注女性和非白人人群的AAA管理。
  • 县际破裂AAA死亡率差异可作为区域卫生资源评估和干预的参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Management of abdominal aortic aneurysms (AAA) has undergone considerable advances over the last two decades. Our aim was to evaluate AAA-related mortality trends in Washington State over a 21-year period and to assess variation in AAA-related mortality by sex, race, and county over the same time period. We hypothesized that a significant decrease in AAA-related mortality in Washington State would be noted. METHODS: Death certificate records were obtained from the Washington State Department of Health from 1996 to 2016. Records in which AAA was listed as an underlying or associated cause of death were selected for analysis. Age-standardized mortality rates for each year were calculated using the 2016 Washington State population as the standard. Mortality trends were compared by sex and race using linear regression. County-specific age-standardized ruptured AAA (rAAA) mortality rates were compared using a Kruskal-Wallis test. RESULTS: Of the 1,014,039 deaths occurring in Washington State during the study period, 4438 (0.4%) had AAA listed as an underlying or associated cause of death (66.1% male; 94.8% white; mean age at death, 79.4 ± 9.3 years). In 64.1% of the cases, AAA was listed as the underlying cause of death. AAA-related mortality rates decreased by 62.1% over the 21 years from 5.8 to 2.2 deaths per 100,000. Notably, there was a statistically significant decrease in rAAA-related mortality rates (from 3.2 to 0.95 per 100,000, a decrease of 0.12 deaths/100,000/year; 95% confidence interval, 0.11-0.14; r2 = 0.95). Men had a significantly steeper decrease in age-standardized AAA-related mortality rates with a 55% decrease (from 6.5 to 3.0 per 100,000) vs a 41% decrease (2.4 to 1.4 per 100,000) among women. Men were younger at the time of death than women (78.1 ± 9.4 years vs 81.9 ± 8.6 years, respectively; P < .001). Individuals who were white had a significantly steeper decrease in age-standardized AAA-related mortality rates with a 53% decrease (from 5.3 to 2.5 per 100,000) compared with a 13% decrease among individuals who were nonwhite (from 1.5 to 1.3 per 100,000). Age-standardized rAAA-related mortality rates varied by county (P < .001). CONCLUSIONS: Age-standardized AAA-related mortality rate has decreased in Washington State between 1996 and 2016, with a notable decrease in the rAAA-related mortality rate. The decrease in AAA-related mortality rates varied by sex and race. Additionally, rAAA-related mortality rates differed between counties. These observations are a first step toward regional population assessments. Future work to understand the sources of variation can influence public health interventions on a state level.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bartek MA, Kessler LG, Talbott JM, et al. Washington State abdominal aortic aneurysm-related mortality shows a steady decline between 1996 and 2016. J Vasc Surg. 2019. PMID: 30850292. doi:10.1016/j.jvs.2018.12.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。